Cargando…
Clinical Advances in Viral-Vectored Influenza Vaccines
Influenza-virus-mediated disease can be associated with high levels of morbidity and mortality, particularly in younger children and older adults. Vaccination is the primary intervention used to curb influenza virus infection, and the WHO recommends immunization for at-risk individuals to mitigate d...
Autores principales: | Sebastian, Sarah, Lambe, Teresa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027524/ https://www.ncbi.nlm.nih.gov/pubmed/29794983 http://dx.doi.org/10.3390/vaccines6020029 |
Ejemplares similares
-
Novel Viral Vectored Vaccines for the Prevention of Influenza
por: Lambe, Teresa
Publicado: (2012) -
Viral vector vaccines
por: McCann, Naina, et al.
Publicado: (2022) -
Viral vector-based influenza vaccines
por: de Vries, Rory D., et al.
Publicado: (2016) -
Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zoster
por: Ulaszewska, Marta, et al.
Publicado: (2023) -
Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice
por: Asthagiri Arunkumar, Guha, et al.
Publicado: (2019)